Page last updated: 2024-10-30

meprobamate and Hodgkin Disease

meprobamate has been researched along with Hodgkin Disease in 2 studies

Meprobamate: A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603)

Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KURZ, GH1
CHOCHOLAC, J1

Other Studies

2 other studies available for meprobamate and Hodgkin Disease

ArticleYear
RETINOPATHY OF OBSCURE (TOXIC?) ORIGIN IN HODGKIN'S DISEASE.
    American journal of ophthalmology, 1964, Volume: 57

    Topics: Anemia; Chloramphenicol; Chlorpromazine; Eye; Glutethimide; Herpes Zoster; Herpes Zoster Ophthalmicu

1964
[FUNCTIONAL DIAGNOSIS OF THE SMALL INTESTINE].
    Radiologia diagnostica, 1964, Volume: 39

    Topics: Bromides; Chlorpromazine; Cholecystitis; Cholelithiasis; Cineradiography; Female; Hodgkin Disease; H

1964